Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-04-11
2006-04-11
Canella, Karen A. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S387100, C530S387200, C530S387300, C530S388100, C530S388150, C530S388220, C530S412000
Reexamination Certificate
active
07026446
ABSTRACT:
The invention relates to a chimeric antibody conjugate comprising an antigen binding region of a non-human antibody and an immunoglobulin constant region which comprises at least one CHdomain or epitope thereof, with the proviso that the constant region is not a naturally occurring FCfragment. A bifunctional molecule for use in labelling an antibody derived from a first species, the bifunctional molecule comprising a binding region which binds to the antibody of the first species or to one or more groups provided thereon, and a constant region derived from an antibody of a second species, the constant region comprising at least one CHdomain or an epitope thereof. The present invention relates to bifunctional molecules and complexes which are useful as positive control reagents in antibody based diagnostic tests. The present invention also relates to polynucleotides encoding these bifunctional molecules, and to diagnostic assays involving the use of these molecules.
REFERENCES:
patent: 4681782 (1987-07-01), Ozkan
patent: 4876194 (1989-10-01), Bjorck et al.
patent: 5096670 (1992-03-01), Harris et al.
patent: 5560911 (1996-10-01), Koren et al.
patent: 5583202 (1996-12-01), Zanetti
patent: 5620889 (1997-04-01), Lynch et al.
patent: 5665558 (1997-09-01), Frame et al.
patent: 5723125 (1998-03-01), Chang et al.
patent: 6057421 (2000-05-01), Muller et al.
patent: 6207815 (2001-03-01), Mezes et al.
patent: 0 617 127 (1994-09-01), None
patent: 02 264863 (1990-10-01), None
patent: WO 91/13166 (1991-09-01), None
patent: WO 97/27486 (1997-07-01), None
Translation of JP 64060388.
The abstract of Borza et al (Biochemistry, 1996, vol. 35, pp. 1925-1934).
The abstract of Gorgani et al (Biochemistry, 1997, vol. 36, pp. 6653-6662).
The abstract of Sekisui-Chem (Database Biotechds, Thomson Derwent, ISI on STN, Accession No. 1990-01279, JP 01060388, Mar. 7, 1989.
Zeltzer and Seeger (Journal of Immunological Methods, 1977, vol. 17, pp. 163-175).
Paul (Fundamental Immunology (text), 1993, pp. 296-302.
Gillies et al, Humn antibodies and Hybridomas, 1990, vol. 1, pp. 47-54, (abstract).
Mueller et al, PNAS, 1990, vol. 87, pp. 5702-5705. (abstract).
Artandi et al, Journal of Immunology, 1991, vol. 146, pp. 603-610.
Mogan, WT, “Human serum histidine rich glycoprotein”, Biochim Biophys Acta, 1978, vol. 535, pp. 319-333.
Lijnen et al, “Physiochemical, immunochemical and functional comparison of human histidine rich glycoprotein and autorosette inhibition factor”, Biochim Biophys Acta, 1983, vol. 742, pp. 109-115.
Angles-Carno et al, “Plasminogen binding by alpha2-antiplasmin and hisidine rich glycoprotein” Biochim Biophys Acta, 1992, vol. 1156, pp. 34-42.
Paul, Fundamental Immunology (textbook), 1993, 3rd edition, p. 250-251.
Yamamoto et al, “Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3”, J of the National Cancer Institute, 1990, vol. 82, pp. 1757-1760.
Kronvall and Williams, “Differences in anti-protein A activity among IgF subgroups”, J of Immunology, 1969, vol. 103, pp. 828-833.
Bjorck and Kronvall, “Purification and some properties of streptococcal protein G” J of Immunology, 1984, vol. 133, pp. 969-974.
Atkinson et al, “Cloning, expression and purification of Ppl-1, a kappa-chain binding protein” Bioseparation, 1995, vol. 5, pp. 359-367.
Better et al, “T-cell targeted immunofusion proteins fromEscherichia coli”, Journal of Biological Chemistry, vol. 270, pp. 14951-14957, Jun. 1995.
Borrebaeck, C.A.K. (ed)., Antibody Engineering (2nded.), Oxford University Press, Inc. pp. 205-255, 1995.
Spooner et al., Human Pathology, vol. 25, No. 6, pp. 606-614, Jun. 1994.
Wright et al., Critical Reviews in Immunology, vol. 12, Nos. 3 & 4, pp. 125-168, 1992.
Pearce et al., Biochemistry and Biology International, vol. 42, No. 6, 1179-1188, Sep. 1997.
Coloma et al., Nature Biotechnology, vol. 15, pp. 159-163, Feb. 1997.
Yanamura et al., Jpn. J. Cancer Res., vol. 187, pp. 405-411, Apr. 1996.
Flamez et al., Journal of Biotechnology, vol. 42, pp. 133-143, 1995.
Sandhu et al., Critical Reviews in Biotechnology, vol. 12, Nos 5 & 6, pp. 437-462, 1992.
Calvo etal., Cancer Biotherapy, vol. 8, No. 1, pp. 95-109, 1993.
Jin et al., Molecular Immunology, vol. 130, No. 18, pp. 1647-1654, 1993.
Atwell John Leslie
Bundesen Peter Gregory
Coia Gregory
Devine Peter Leonard
Kortt Alexander Andrew
Canella Karen A.
Diatech Pty Ltd.
Frommer Lawrence & Haug
Kowalski Thomas J.
LandOfFree
Bifunctional molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bifunctional molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bifunctional molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3561902